Inhibition of the HER2-YB1-AR axis with lapatinib synergistically enhances enzalutamide anti-tumor efficacy in castration resistant prostate cancer

Masaki Shiota, Jennifer L. Bishop, Ario Takeuchi, Ka Mun Nip, Thomas Cordonnier, Eliana Beraldi, Hidetoshi Kuruma, Martin E. Gleave, Amina Zoubeidi

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint Dive into the research topics of 'Inhibition of the HER2-YB1-AR axis with lapatinib synergistically enhances enzalutamide anti-tumor efficacy in castration resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences